Skip to content

Clinical registration study on functional verification of warfarin individual drug decision making software

Clinical registration study on functional verification of warfarin individual drug decision making software

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052089
Enrollment
Unknown
Registered
2021-10-17
Start date
2020-12-26
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thromboembolic disease

Interventions

test group:None

Sponsors

Center for Clinical Pharmacology, the Third Xiangya Hospital, Central South University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) patients who will or are taking warfarin; (2) patients who can be followed up at least once; (3) Able to provide written informed consent, communicate well with researchers and complete the study in accordance with the research regulations.

Exclusion criteria

Exclusion criteria: (1) Medical records cannot be provided or are incomplete.

Design outcomes

Primary

MeasureTime frame
international normalized ratio;

Countries

China

Contacts

Public ContactLiming Liu

The Third Xiangya Hospital, Central South University

syy09826@163.com+86 0731-89918665

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026